Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valeria Pozzilli

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2025
Epilepsy in MS and its association with cognitive and psychological burdenValeria Pozzilli, Carla Tortorella, Luca Prosperini, et al.
Brain : a Journal of Neurology|September 8, 2025
The postdoc paradox: a career without a pathJonathan Pansieri, Sandy Figiel, David Menassa, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Neurology and Therapy|September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of FrailtyGina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2025
Epilepsy in MS and its association with cognitive and psychological burdenValeria Pozzilli, Carla Tortorella, Luca Prosperini, et al.
Brain : a Journal of Neurology|September 8, 2025
The postdoc paradox: a career without a pathJonathan Pansieri, Sandy Figiel, David Menassa, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Neurology and Therapy|September 19, 2025
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of FrailtyGina Ferrazzano, Roberta Fantozzi, Shalom Haggiag, et al.
Pageof 4